15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
19959361	2	Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.	Huazhong Agricultural University
18499454	28	Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase.	University of Illinois At Chicago
17892940	54	Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.	Meiji Seika Kaisha
17263522	40	Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).	National Institute of Immunology
23806111	5	Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.	University of London
19682901	20	Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).	Affinium Pharmaceuticals
19682900	15	2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.	Affinium Pharmaceuticals
24739388	14	Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor.	University of Wuerzburg
11527706	65	Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.	Glaxosmithkline
11514139	41	1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI).	Glaxosmithkline
12699381	31	Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.	Glaxosmithkline
12109908	29	Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).	Glaxosmithkline